Francesca Fontana

A little context, pharmaceutical companies including Lilly and Novo Nordisk, which currently dominate the obesity market with injectable drugs like Zepbound and Wegovy, have been testing pills that could help people lose weight. The market for weight loss drugs has been on fire, and analysts say it could reach $100 billion by the end of the decade.

On Thursday, Lilly said its daily pill met its goals in a trial, helping diabetics lower their blood sugar and lose weight. And these results are the first from several studies of the pill expected this year. And they were certainly celebrated by investors, because Lilly shares surged 14% on Thursday.

On Thursday, Lilly said its daily pill met its goals in a trial, helping diabetics lower their blood sugar and lose weight. And these results are the first from several studies of the pill expected this year. And they were certainly celebrated by investors, because Lilly shares surged 14% on Thursday.

Now let's circle back to UnitedHealth, the healthcare conglomerate and parent of UnitedHealthcare, America's largest health insurer. UnitedHealth's stock took a nosedive on Thursday after the company slashed its annual outlook and posted quarterly earnings that fell short of Wall Street's expectations. This is a rare stumble for the company.

Now let's circle back to UnitedHealth, the healthcare conglomerate and parent of UnitedHealthcare, America's largest health insurer. UnitedHealth's stock took a nosedive on Thursday after the company slashed its annual outlook and posted quarterly earnings that fell short of Wall Street's expectations. This is a rare stumble for the company.

You know, it typically delivers a steady stream of increased earnings and better than projected financial performance. So what caused the unexpectedly disappointing results? Well, higher than expected medical costs in its Medicare business. This is an issue that has affected the entire industry over the past year, but until now, it's been not so significant a problem at UnitedHealth.

You know, it typically delivers a steady stream of increased earnings and better than projected financial performance. So what caused the unexpectedly disappointing results? Well, higher than expected medical costs in its Medicare business. This is an issue that has affected the entire industry over the past year, but until now, it's been not so significant a problem at UnitedHealth.

The stock ended up plummeting 22% on Thursday. Last but not least, some news from Netflix. The streaming giant has some pretty ambitious goals, The Wall Street Journal reported this week, including joining the elite club of companies with a market cap of $1 trillion or more, which includes tech giants like Apple and Nvidia. The company also aims to double its revenue to about $80 billion by 2030.

The stock ended up plummeting 22% on Thursday. Last but not least, some news from Netflix. The streaming giant has some pretty ambitious goals, The Wall Street Journal reported this week, including joining the elite club of companies with a market cap of $1 trillion or more, which includes tech giants like Apple and Nvidia. The company also aims to double its revenue to about $80 billion by 2030.

So where's Netflix at right now? Well, it's got a market cap of more than $400 billion, for starters, and the company has boosted its performance in recent years by raising prices, limiting password sharing, and starting an ad business. Another thing Netflix has going for it, it's been relatively unscathed by the market turmoil related to Trump's tariffs, at least so far.

So where's Netflix at right now? Well, it's got a market cap of more than $400 billion, for starters, and the company has boosted its performance in recent years by raising prices, limiting password sharing, and starting an ad business. Another thing Netflix has going for it, it's been relatively unscathed by the market turmoil related to Trump's tariffs, at least so far.

Netflix shares gained 4.8% Tuesday and, on a weekly basis, rose about 6%. We also got the latest quarterly results from Netflix later in the week, after market close on Thursday, in which it reported a record quarterly profit. But, as we know, the market was closed on Friday, so the stock is definitely one to keep an eye on Monday. And now you know what's news in markets this week.

Netflix shares gained 4.8% Tuesday and, on a weekly basis, rose about 6%. We also got the latest quarterly results from Netflix later in the week, after market close on Thursday, in which it reported a record quarterly profit. But, as we know, the market was closed on Friday, so the stock is definitely one to keep an eye on Monday. And now you know what's news in markets this week.

You can read about more stocks that moved on the week's news in The Score, my column in the Wall Street Journal's Exchange section. Today's show was produced by Zoe Kolkin and Anthony Bansi with supervising producer Talia Arbel. I'm Francesca Fontana. Have a great weekend and see you next Saturday.

You can read about more stocks that moved on the week's news in The Score, my column in the Wall Street Journal's Exchange section. Today's show was produced by Zoe Kolkin and Anthony Bansi with supervising producer Talia Arbel. I'm Francesca Fontana. Have a great weekend and see you next Saturday.

Hey, listeners, it's Saturday, April 12th. I'm Francesca Fontana for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get to it. So what to talk about this week? I mean, it was so slow. There was no big news. I'm fully kidding.

Hey, listeners, it's Saturday, April 12th. I'm Francesca Fontana for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get to it. So what to talk about this week? I mean, it was so slow. There was no big news. I'm fully kidding.

This week, like last week, was full of trade turmoil and giant market swings. Really, we can divide it into before Wednesday and after Wednesday, a.k.a. before and after Trump's big about face on a bunch of the latest tariffs.

This week, like last week, was full of trade turmoil and giant market swings. Really, we can divide it into before Wednesday and after Wednesday, a.k.a. before and after Trump's big about face on a bunch of the latest tariffs.

So before Wednesday, the market was digesting all of the latest threats of retaliation from China in response to Trump's tariffs, as well as big Wall Street players weighing in and voicing their concerns like JPMorgan's Jamie Dimon, and BlackRock's Larry Fink. In contrast, Trump told everyone to, quote, be cool via Truth Social, but clearly things in the market were not cool.